Yi-Wen Huang

A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19)

Cheng‐Pin Chen, Yi‐Chun Lin, Tsung‐Chia Chen et al. · PLoS ONE · 2020 · 81 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trials

Cathrine Axfors, Andreas M. Schmitt, Perrine Janiaud et al. · medRxiv · 2020 · 79 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +13

Curbing COVID-19 progression and mortality with traditional Chinese medicine among hospitalized patients with COVID-19: A propensity score-matched analysis

Yu-Hwei Tseng, Jui‐Shan Lin, Sheng‐Mou Hou et al. · Pharmacological Research · 2022 · 57 citations · Full text

Medicine, Infectious Diseases, Clinical Epidemiology +9

Twelve-dose weekly rifapentine plus isoniazid for latent tuberculosis infection: A multicentre randomised controlled trial in Taiwan

Hsin‐Yun Sun, Yi-Wen Huang, Wei‐Chang Huang et al. · Tuberculosis · 2018 · 51 citations · Full text

Public Health, Pharmacology, Pharmacotherapy +15

δ¹-Pyrroline-5-carboxylic Acid Formed by Proline Dehydrogenase from the<i>Bacillus subtilis</i>ssp. natto Expressed in<i>Escherichia coli</i>as a Precursor for 2-Acetyl-1-pyrroline

Tzou‐Chi Huang, Yi-Wen Huang, Hui-Ju Hung et al. · Journal of Agricultural and Food Chemistry · 2007 · 47 citations

Life Sciences, Biochemistry, Microbiology +13